Is there a difference between kid and adult sunscreen? Experts weigh in

Dermatologists explain the key differences between kid and adult sunscreen, whether kids need a higher SPF and which formulas ...
Malay Mail

Eczema isn’t ‘just dry skin’ — and social media cures could make it worse

Persistent itching, dry skin and redness are often dismissed as minor skin problems.However, for eczema sufferers, these ...

From Flare to Full-Cycle Care: Triple Paste® Helps Break the Eczema Loop with New Dual-Action Skin Barrier Eczema Care System

For the 31 million Americans living with eczema1, the challenge isn't just managing flare-ups when they happen. It's navigating the ongoing cycle of itching, irritation and skin barrier disruption ...
The Journal Gazette

Living with Chronic Hand Eczema: When Everyday Touch Becomes Painful

Her hands often became swollen, blistered, and cracked — sometimes so raw that even light touch caused burning. While ...
Healio

Team-based telehealth model as effective as in-person care for eczema

Adults and children with eczema who received care via a team-based connected telehealth model incorporating primary care ...

Scars from eczema and vitiligo run more than skin deep

Visible skin conditions can cause mental health problems, especially among young patients, but help is at hand. Read more at ...

Vitamin D deficiency 6 'leg and skin' signs - including 'symptom sitting in chair'

Below are six key indicators of vitamin D deficiency that can show up on the skin and legs. Delayed wound healing. If you're ...

Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis

Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic ...
Healio

FDA approves bimonthly dosing regimen for Ebglyss in adults, children with eczema

Please provide your email address to receive an email when new articles are posted on . Previously approved for once monthly dosing, lebrikizumab 250 mg/2 mL injection is now available as a ...

FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months

FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of February 23, 2027Application supported by positive results from Phase ...

Arcutis: FDA to Review Zoryve for Atopic Dermatitis in Infants

Arcutis Biotherapeutics said the U.S. Food and Drug Administration has accepted its application seeking expanded approval of its Zoryve topical treatment for infants with atopic dermatitis, the most ...

Incyte's Atopic Dermatitis Cream Recommended for Approval in Europe

Incyte's cream for the treatment of moderate atopic dermatitis in adults has been recommended for approval by the European Medicines Agency. The agency issued a positive opinion on Incyte's Opzelura ...